{"transactions":[{"id":1705706,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":96074,"kind":"person","name":"Regan Barry J.","position":1,"cik":"0001746313","reported_name":"Regan Barry J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Operations"}}],"security":"Common Stock","published_at":"2023-12-19T21:35:56.000Z","date":"2023-12-18","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1675,"price":121.8503,"value":204099.2525,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs.  This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 50,680 unvested restricted stock units, 18,776 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 13,288 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 3,340 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 7,068 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 8,208 of which were granted on November 19, 2020 and shall vest through November 19, 2024."}],"balance_after":58469,"source":{"system":"sec-edgar","filing":"0001093557-23-000252","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355723000252/edgardoc.xml","form_type":"4"}},{"id":1735194,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":96074,"kind":"person","name":"Regan Barry J.","position":1,"cik":"0001746313","reported_name":"Regan Barry J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Operations"}}],"security":"Common Stock","published_at":"2023-11-21T00:26:38.000Z","date":"2023-11-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":4106,"price":104.063,"value":427282.678,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs.  This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 54,024 unvested restricted stock units, 18,776 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 13,288 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 6,684 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 7,068 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 8,208 of which were granted on November 19, 2020 and shall vest through November 19, 2024."}],"balance_after":60144,"source":{"system":"sec-edgar","filing":"0001093557-23-000229","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355723000229/edgardoc.xml","form_type":"4"}},{"id":1746983,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":96074,"kind":"person","name":"Regan Barry J.","position":1,"cik":"0001746313","reported_name":"Regan Barry J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Operations"}}],"security":"Common Stock","published_at":"2023-11-08T21:05:46.000Z","date":"2023-11-08","kind":"sale","planned":false,"acquired":false,"shares":2019,"price":95.22,"value":192249.18,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On November 1, 2022, Mr. Regan adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Regan.  The shares set forth above were sold pursuant to the 10b5-1 Plan that was intended to comply with prior version of Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 62,232 unvested restricted stock units, 18,776 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 13,288 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 6,684 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 7,068 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 16,416 of which were granted on November 19, 2020 and shall vest through November 19, 2024."}],"balance_after":64250,"source":{"system":"sec-edgar","filing":"0001093557-23-000224","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355723000224/edgardoc.xml","form_type":"4"}},{"id":1832396,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":96074,"kind":"person","name":"Regan Barry J.","position":1,"cik":"0001746313","reported_name":"Regan Barry J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Operations"}}],"security":"Common Stock","published_at":"2023-07-10T21:39:47.000Z","date":"2023-07-10","kind":"sale","planned":false,"acquired":false,"shares":1989,"price":128.05,"value":254691.45,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On November 1, 2022, Mr. Regan adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Regan.  The shares set forth above were sold pursuant to the 10b5-1 Plan that was intended to comply with prior version of Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 62,232 unvested restricted stock units, 18,776 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 13,288 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 6,684 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 7,068 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 16,416 of which were granted on November 19, 2020 and shall vest through November 19, 2024."}],"balance_after":66269,"source":{"system":"sec-edgar","filing":"0001093557-23-000162","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355723000162/edgardoc.xml","form_type":"4"}},{"id":1916682,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":96074,"kind":"person","name":"Regan Barry J.","position":1,"cik":"0001746313","reported_name":"Regan Barry J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Operations"}}],"security":"Common Stock","published_at":"2023-04-20T22:39:43.000Z","date":"2023-04-20","kind":"sale","planned":false,"acquired":false,"shares":2214,"price":124.5,"value":275643.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On November 1, 2022, Mr. Regan adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Regan.  The shares set forth above were sold pursuant to the 10b5-1 Plan. The shares set forth above were sold pursuant to the 10b5-1 Plan that was intended to comply with prior version of Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 62,232 unvested restricted stock units, 18,776 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 13,288 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 6,684 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 7,068 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 16,416 of which were granted on November 19, 2020 and shall vest through November 19, 2024."}],"balance_after":68258,"source":{"system":"sec-edgar","filing":"0001093557-23-000109","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355723000109/edgardoc.xml","form_type":"4"}},{"id":1955052,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":96074,"kind":"person","name":"Regan Barry J.","position":1,"cik":"0001746313","reported_name":"Regan Barry J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Operations"}}],"security":"Common Stock","published_at":"2023-03-14T20:46:57.000Z","date":"2023-03-13","kind":"sale","acquired":false,"shares":2010,"price":106.27,"value":213602.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"On November 1, 2022, Mr. Regan adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Regan.  The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 62,232 unvested restricted stock units, 18,776 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 13,288 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 6,684 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 7,068 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 16,416 of which were granted on November 19, 2020 and shall vest through November 19, 2024."}],"balance_after":70472,"source":{"system":"sec-edgar","filing":"0001093557-23-000081","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355723000081/edgardoc.xml","form_type":"4"}},{"id":1955051,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":96074,"kind":"person","name":"Regan Barry J.","position":1,"cik":"0001746313","reported_name":"Regan Barry J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Operations"}}],"security":"Common Stock","published_at":"2023-03-14T20:46:57.000Z","date":"2023-03-10","kind":"disposition_to_issuer","acquired":false,"shares":3274,"price":111.399,"value":364720.326,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs.  This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 62,232 unvested restricted stock units, 18,776 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 13,288 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 6,684 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 7,068 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 16,416 of which were granted on November 19, 2020 and shall vest through November 19, 2024."}],"balance_after":72482,"source":{"system":"sec-edgar","filing":"0001093557-23-000081","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355723000081/edgardoc.xml","form_type":"4"}},{"id":1955050,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":96074,"kind":"person","name":"Regan Barry J.","position":1,"cik":"0001746313","reported_name":"Regan Barry J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Operations"}}],"security":"Common Stock","published_at":"2023-03-14T20:46:57.000Z","date":"2023-03-10","kind":"disposition_to_issuer","acquired":false,"shares":2406,"price":111.399,"value":268025.994,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs.  This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 62,232 unvested restricted stock units, 18,776 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 13,288 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 6,684 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 7,068 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 16,416 of which were granted on November 19, 2020 and shall vest through November 19, 2024."}],"balance_after":75756,"source":{"system":"sec-edgar","filing":"0001093557-23-000081","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355723000081/edgardoc.xml","form_type":"4"}},{"id":1959483,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":96074,"kind":"person","name":"Regan Barry J.","position":1,"cik":"0001746313","reported_name":"Regan Barry J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Operations"}}],"security":"Common Stock","published_at":"2023-03-10T21:01:41.000Z","date":"2023-03-08","kind":"grant","acquired":true,"shares":18776,"price":0.001,"value":18.776,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting in three equal annual installments from the date of grant.  Share units represent a contingent right to receive one share of DexCom, Inc. Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 62,632 unvested restricted stock units, 18,776 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 13,288 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 6,684 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 7,068 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 16,416 of which were granted on November 19, 2020 and shall vest through November 19, 2024."}],"balance_after":78162,"source":{"system":"sec-edgar","filing":"0001093557-23-000059","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355723000059/edgardoc.xml","form_type":"4"}},{"id":2040663,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":96074,"kind":"person","name":"Regan Barry J.","position":1,"cik":"0001746313","reported_name":"Regan Barry J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Operations"}}],"security":"Common Stock","published_at":"2023-01-31T21:07:28.000Z","date":"2023-01-30","kind":"sale","acquired":false,"shares":2213,"price":106.12,"value":234843.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On November 1, 2022, Mr. Regan adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Regan.  The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 57,172 unvested restricted stock units, 19,936 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 6,684 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 14,136 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 16,416 of which were granted on November 19, 2020 and shall vest through November 19, 2024."}],"balance_after":59386,"source":{"system":"sec-edgar","filing":"0001093557-23-000016","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355723000016/edgardoc.xml","form_type":"4"}},{"id":2107452,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":96074,"kind":"person","name":"Regan Barry J.","position":1,"cik":"0001746313","reported_name":"Regan Barry J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Operations"}}],"security":"Common Stock","published_at":"2022-11-22T23:24:48.000Z","date":"2022-11-21","kind":"disposition_to_issuer","acquired":false,"shares":3781,"price":112.6204,"value":425817.7324,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs.  This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 57,172 unvested restricted stock units, 19,936 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 6,684 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 14,136 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 16,416 of which were granted on November 19, 2020 and shall vest through November 19, 2024."}],"balance_after":61599,"source":{"system":"sec-edgar","filing":"0001093557-22-000178","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355722000178/edgardoc.xml","form_type":"4"}},{"id":2314398,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":96074,"kind":"person","name":"Regan Barry J.","position":1,"cik":"0001746313","reported_name":"Regan Barry J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Global Operations"}}],"security":"Common Stock","published_at":"2022-03-30T21:49:52.000Z","date":"2022-03-29","kind":"sale","acquired":false,"shares":1106,"price":500,"value":553000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On September 14, 2021, Mr. Regan adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Regan.  The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 16,345 unvested restricted stock units, 4,984 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 1,671 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 3,534 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 6,156 of which were granted on November 19, 2020 and shall vest through November 19, 2024."}],"balance_after":16345,"source":{"system":"sec-edgar","filing":"0001093557-22-000078","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355722000078/edgardoc.xml","form_type":"4"}},{"id":2340431,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":96074,"kind":"person","name":"Regan Barry J.","position":1,"cik":"0001746313","reported_name":"Regan Barry J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Global Operations"}}],"security":"Common Stock","published_at":"2022-03-11T00:27:40.000Z","date":"2022-03-09","kind":"disposition_to_issuer","acquired":false,"shares":661,"price":406.0567,"value":268403.4787,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs.  This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 16,345 unvested restricted stock units, 4,984 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 1,671 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 3,534 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 6,156 of which were granted on November 19, 2020 and shall vest through November 19, 2024."}],"balance_after":17451,"source":{"system":"sec-edgar","filing":"0001093557-22-000052","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355722000052/edgardoc.xml","form_type":"4"}},{"id":2340430,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":96074,"kind":"person","name":"Regan Barry J.","position":1,"cik":"0001746313","reported_name":"Regan Barry J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Global Operations"}}],"security":"Common Stock","published_at":"2022-03-11T00:27:40.000Z","date":"2022-03-08","kind":"grant","acquired":true,"shares":4984,"price":0.001,"value":4.984,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting in three equal annual installments from the date of grant.  Share units represent a contingent right to receive one share of DexCom, Inc. Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 16,345 unvested restricted stock units, 4,984 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 1,671 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 3,534 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 6,156 of which were granted on November 19, 2020 and shall vest through November 19, 2024."}],"balance_after":18112,"source":{"system":"sec-edgar","filing":"0001093557-22-000052","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355722000052/edgardoc.xml","form_type":"4"}},{"id":2468339,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":96074,"kind":"person","name":"Regan Barry J.","position":1,"cik":"0001746313","reported_name":"Regan Barry J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Operations"}}],"security":"Common Stock","published_at":"2021-12-17T21:39:31.000Z","date":"2021-12-15","kind":"grant","acquired":true,"shares":1671,"price":0.001,"value":1.671,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting over a 36 month period from the date of grant as follows: 1/2 shall vest 24 months from the Grant Date, 1/8 shall vest 27 months from the Grant Date, 1/8 shall vest 30 months from the grant date, 1/8 shall vest 33 months from the Grant Date, and the remaining balance shall vest 36 months from the Grant Date. Share units represent a contingent right to receive one share of DexCom Inc. Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 13,128 unvested restricted stock units, 1,671 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, and 6,156 of which were granted on November 19, 2020 and shall vest through November 19, 2024."}],"balance_after":13128,"source":{"system":"sec-edgar","filing":"0001093557-21-000286","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355721000286/edgardoc.xml","form_type":"4"}},{"id":2474158,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":96074,"kind":"person","name":"Regan Barry J.","position":1,"cik":"0001746313","reported_name":"Regan Barry J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Operations"}}],"security":"Common Stock","published_at":"2021-12-14T21:15:25.000Z","date":"2021-12-13","kind":"sale","acquired":false,"shares":1214,"price":563.93,"value":684611.02,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On September 14, 2021, Mr. Regan adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Regan.  The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 11,457 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, and 6,156 of which were granted on November 19, 2020 and shall vest through November 19, 2024."}],"balance_after":11457,"source":{"system":"sec-edgar","filing":"0001093557-21-000274","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355721000274/edgardoc.xml","form_type":"4"}},{"id":2499203,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":96074,"kind":"person","name":"Regan Barry J.","position":1,"cik":"0001746313","reported_name":"Regan Barry J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Operations"}}],"security":"Common Stock","published_at":"2021-11-23T23:57:26.000Z","date":"2021-11-22","kind":"sale","acquired":false,"shares":837,"price":638.65,"value":534550.05,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs.  This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 11,457 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, and 6,156 of which were granted on November 19, 2020 and shall vest through November 19, 2024."}],"balance_after":12671,"source":{"system":"sec-edgar","filing":"0001093557-21-000263","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355721000263/edgardoc.xml","form_type":"4"}},{"id":2797713,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":96074,"kind":"person","name":"Regan Barry J.","position":1,"cik":"0001746313","reported_name":"Regan Barry J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Operations"}}],"security":"Common Stock","published_at":"2021-03-11T00:29:04.000Z","date":"2021-03-08","kind":"grant","acquired":true,"shares":5301,"price":0.001,"value":5.301,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting in three equal annual installments from the date of grant.  Share units represent a contingent right to receive one share of DexCom, Inc. Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 13,508 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, and 8,207 of which were granted on November 19, 2020 and shall vest through November 19 2024."}],"balance_after":13508,"source":{"system":"sec-edgar","filing":"0001093557-21-000054","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355721000054/edgardoc.xml","form_type":"4"}},{"id":2971637,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":96074,"kind":"person","name":"Regan Barry J.","position":1,"cik":"0001746313","reported_name":"Regan Barry J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Operations"}}],"security":"Common Stock","published_at":"2020-11-20T22:17:17.000Z","date":"2020-11-19","kind":"grant","acquired":true,"shares":8207,"price":0.001,"value":8.207,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of RSUs that vest in four annual installments on November 19, 2021, November 19, 2022, November 19, 2023 and November 19, 2024. Share units\nrepresent a contingent right to receive one share of Dexcom, Inc. common stock upon settlement for no consideration."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents a grant of RSUs that vest in four annual installments on November 19, 2021, November 19, 2022, November 19, 2023 and November 19, 2024. Share units\nrepresent a contingent right to receive one share of Dexcom, Inc. common stock upon settlement for no consideration."}],"balance_after":8207,"source":{"system":"sec-edgar","filing":"0001093557-20-000310","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355720000310/edgardoc.xml","form_type":"4"}},{"id":2981135,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":96074,"kind":"person","name":"Regan Barry J.","position":1,"cik":"0001746313","reported_name":"Regan Barry J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Operations"}}],"security":"Stock Option (right to buy)","published_at":"2020-11-13T15:03:16.000Z","date":"2020-11-11","kind":"disposition_to_issuer","acquired":false,"shares":57153,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":24.49,"expiration_date":"2028-07-24","underlying":"Ordinary Shares","underlying_shares":57153},"source":{"system":"sec-edgar","filing":"0001686266-20-000011","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000168626620000011/primary_doc.xml","form_type":"4"}},{"id":2981134,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":96074,"kind":"person","name":"Regan Barry J.","position":1,"cik":"0001746313","reported_name":"Regan Barry J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Operations"}}],"security":"Stock Option (right to buy)","published_at":"2020-11-13T15:03:16.000Z","date":"2020-11-11","kind":"disposition_to_issuer","acquired":false,"shares":22241,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":27.84,"expiration_date":"2029-07-26","underlying":"Ordinary Shares","underlying_shares":22241},"source":{"system":"sec-edgar","filing":"0001686266-20-000011","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000168626620000011/primary_doc.xml","form_type":"4"}},{"id":2981133,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":96074,"kind":"person","name":"Regan Barry J.","position":1,"cik":"0001746313","reported_name":"Regan Barry J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Operations"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2020-11-13T15:03:16.000Z","date":"2020-11-11","kind":"disposition_to_issuer","acquired":false,"shares":14462,"price":30.75,"value":444706.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"In connection with the Offer, each performance share unit in respect of Shares (a \"Wright PSU\") that was outstanding and unvested immediately prior to the Acceptance Time vested in full at the Acceptance Time, and, at the Closing, was cancelled in exchange for a cash payment equal to the product of (a) $30.75 multiplied by (b) the total number of Shares subject to such Wright PSU as of immediately prior to the Acceptance Time determined based on the maximum achievement of the applicable performance condition, without interest and less applicable withholding taxes."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001686266-20-000011","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000168626620000011/primary_doc.xml","form_type":"4"}},{"id":2981132,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":96074,"kind":"person","name":"Regan Barry J.","position":1,"cik":"0001746313","reported_name":"Regan Barry J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Operations"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2020-11-13T15:03:16.000Z","date":"2020-11-11","kind":"grant","acquired":true,"shares":14462,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"In connection with the Offer, each performance share unit in respect of Shares (a \"Wright PSU\") that was outstanding and unvested immediately prior to the Acceptance Time vested in full at the Acceptance Time, and, at the Closing, was cancelled in exchange for a cash payment equal to the product of (a) $30.75 multiplied by (b) the total number of Shares subject to such Wright PSU as of immediately prior to the Acceptance Time determined based on the maximum achievement of the applicable performance condition, without interest and less applicable withholding taxes."}],"balance_after":14462,"source":{"system":"sec-edgar","filing":"0001686266-20-000011","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000168626620000011/primary_doc.xml","form_type":"4"}},{"id":2981131,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":96074,"kind":"person","name":"Regan Barry J.","position":1,"cik":"0001746313","reported_name":"Regan Barry J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Operations"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2020-11-13T15:03:16.000Z","date":"2020-11-11","kind":"disposition_to_issuer","acquired":false,"shares":17909,"price":30.75,"value":550701.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"See Exhibit 99.1."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001686266-20-000011","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000168626620000011/primary_doc.xml","form_type":"4"}},{"id":2981130,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":96074,"kind":"person","name":"Regan Barry J.","position":1,"cik":"0001746313","reported_name":"Regan Barry J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Operations"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2020-11-13T15:03:16.000Z","date":"2020-11-11","kind":"disposition_to_issuer","acquired":false,"shares":18190,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents Shares issuable upon vesting of the 2020 RSUs which did not vest at the Acceptance Time and were cancelled and forfeited at the Closing for no Offer Consideration or other consideration.  See note (5) below for the treatment of the Wright 2020 RSUs in connection with the Offer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 16,398 Shares issuable upon vesting of the Wright RSUs and 1,511 Shares issuable upon vesting of the 2020 RSUs.  See Note (5) below for the treatment of Wright RSUs and Wright 2020 RSUs in connection with the Offer."}],"balance_after":17909,"source":{"system":"sec-edgar","filing":"0001686266-20-000011","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000168626620000011/primary_doc.xml","form_type":"4"}},{"id":2981129,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":96074,"kind":"person","name":"Regan Barry J.","position":1,"cik":"0001746313","reported_name":"Regan Barry J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Operations"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2020-11-13T15:03:16.000Z","date":"2020-11-11","kind":"other","acquired":false,"shares":6412,"price":30.75,"value":197169.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 4, 2019, Wright Medical Group N.V. (the \"Issuer\") entered into a purchase agreement (the \"Purchase Agreement\") with Stryker Corporation and its subsidiary, Stryker B.V. (the \"Purchaser\").  Pursuant to the terms of the Purchase Agreement, the Purchaser commenced a tender offer for all the outstanding ordinary shares, par value EUR0.03 per share (\"Shares\"), of the Issuer (the \"Offer\"), and, on November 11, 2020 (the \"Acceptance Time\"), the Purchaser accepted all of the Shares that were validly tendered and not properly withdrawn pursuant to the Offer as of the Acceptance Time, including 6,412 Shares tendered by the reporting person, in exchange for a cash payment equal to $30.75 per Share, without interest and less applicable withholding taxes (the \"Offer Consideration\"), which Offer Consideration will be paid as promptly as practicable following the Closing (as defined in the Purchase Agreement)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 16,398 Shares issuable upon vesting of restricted stock units in respect of Shares (collectively, \"Wright RSUs\") and 19,701 Shares issuable upon vesting of Wright RSUs granted on July 23, 2020 (the \"2020 RSUs\").  See note (5) below for the treatment of such Wright RSUs and Wright 2020 RSUs in connection with the Offer."}],"balance_after":36099,"source":{"system":"sec-edgar","filing":"0001686266-20-000011","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000168626620000011/primary_doc.xml","form_type":"4"}},{"id":3052327,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":96074,"kind":"person","name":"Regan Barry J.","position":1,"cik":"0001746313","reported_name":"Regan Barry J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Operations"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2020-08-19T16:05:57.000Z","date":"2020-08-17","kind":"sale","acquired":false,"shares":1788,"price":30.13,"value":53872.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, to cover the estimated tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 10,974 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 25,125 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan."}],"balance_after":42511,"source":{"system":"sec-edgar","filing":"0001235802-20-000100","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580220000100/primary_doc.xml","form_type":"4"}},{"id":3075567,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":96074,"kind":"person","name":"Regan Barry J.","position":1,"cik":"0001746313","reported_name":"Regan Barry J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Operations"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2020-07-27T16:29:50.000Z","date":"2020-07-23","kind":"grant","acquired":true,"shares":19701,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These ordinary shares will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan.  The grant agreement contemplates that the shares will vest pro rata through the closing of the previously announced Stryker transaction, and shares unvested at closing will be cancelled."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 16,461 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan, 26,932 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan and 203 ordinary shares acquired under the Wright Medical Group N.V. Amended and Restated Employee Stock Purchase Plan."}],"balance_after":44299,"source":{"system":"sec-edgar","filing":"0001235802-20-000090","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580220000090/primary_doc.xml","form_type":"4"}},{"id":3238073,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":96074,"kind":"person","name":"Regan Barry J.","position":1,"cik":"0001746313","reported_name":"Regan Barry J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Operations"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2020-03-02T16:32:45.000Z","date":"2020-02-28","kind":"sale","acquired":false,"shares":15486,"price":30.05,"value":465354.3,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 16,461 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan, 7,231 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan and 203 ordinary shares acquired under the Wright Medical Group N.V. Amended and Restated Employee Stock Purchase Plan."}],"balance_after":24598,"source":{"system":"sec-edgar","filing":"0001235802-20-000011","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580220000011/primary_doc.xml","form_type":"4"}},{"id":3439925,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":96074,"kind":"person","name":"Regan Barry J.","position":1,"cik":"0001746313","reported_name":"Regan Barry J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Operations"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2019-08-13T16:20:07.000Z","date":"2019-08-13","kind":"purchase","acquired":true,"shares":10000,"price":21.5,"value":215000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 21,947 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan, 7,231 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan and 703 ordinary shares acquired under the Wright Medical Group N.V. Amended and Restated Employee Stock Purchase Plan."}],"balance_after":39881,"source":{"system":"sec-edgar","filing":"0001235802-19-000101","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580219000101/primary_doc.xml","form_type":"4"}},{"id":3453229,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":96074,"kind":"person","name":"Regan Barry J.","position":1,"cik":"0001746313","reported_name":"Regan Barry J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Operations"}}],"security":"Stock Option (right to buy)","published_at":"2019-07-30T19:09:03.000Z","date":"2019-07-26","kind":"grant","acquired":true,"shares":22241,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests with respect to 25% of the shares on July 26, 2020 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments."}],"balance_after":22241,"derivative":{"exercise_price":27.84,"expiration_date":"2029-07-26","underlying":"Ordinary Shares","underlying_shares":22241},"source":{"system":"sec-edgar","filing":"0001235802-19-000096","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580219000096/primary_doc.xml","form_type":"4"}},{"id":3453228,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":96074,"kind":"person","name":"Regan Barry J.","position":1,"cik":"0001746313","reported_name":"Regan Barry J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Operations"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2019-07-30T19:09:03.000Z","date":"2019-07-26","kind":"grant","acquired":true,"shares":7231,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These ordinary shares will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 21,947 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan, 7,231 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan and 703 ordinary shares acquired under the Wright Medical Group N.V. Amended and Restated Employee Stock Purchase Plan."}],"balance_after":29881,"source":{"system":"sec-edgar","filing":"0001235802-19-000096","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580219000096/primary_doc.xml","form_type":"4"}},{"id":3860843,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":96074,"kind":"person","name":"Regan Barry J.","position":1,"cik":"0001746313","reported_name":"Regan Barry J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. Vice President, Operations"}}],"security":"Stock Option (right to buy)","published_at":"2018-07-26T16:34:13.000Z","date":"2018-07-24","kind":"grant","acquired":true,"shares":57153,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests with respect to 25% of the shares on July 24, 2019 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments."}],"balance_after":57153,"derivative":{"exercise_price":24.49,"expiration_date":"2028-07-24","underlying":"Ordinary Shares","underlying_shares":57153},"source":{"system":"sec-edgar","filing":"0001235802-18-000106","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580218000106/primary_doc.xml","form_type":"4"}},{"id":3860842,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":96074,"kind":"person","name":"Regan Barry J.","position":1,"cik":"0001746313","reported_name":"Regan Barry J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. Vice President, Operations"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2018-07-26T16:34:13.000Z","date":"2018-07-24","kind":"grant","acquired":true,"shares":21947,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These ordinary shares will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These ordinary shares will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan."}],"balance_after":21947,"source":{"system":"sec-edgar","filing":"0001235802-18-000106","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580218000106/primary_doc.xml","form_type":"4"}}]}